[{"NetIncomeLoss_1_Q1_USD":-128642000.0,"FinanceLeaseInterestPaymentOnLiability_1_Q1_USD":776000.0,"OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_1_Q1_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":30147000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":276700000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-38743000.0,"InventoryFinishedGoods_0_Q1_USD":7155000.0,"InterestPaidNet_1_Q1_USD":5182000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_1_Q1_USD":1819000.0,"IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease_10_Q1_USD":0.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q1_USD":266050000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":45100000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":70188602.0,"AccruedRoyaltiesCurrent_0_Q1_USD":16181000.0,"MarketableSecuritiesCurrent_0_Q1_USD":841774000.0,"DeferredIncomeTaxLiabilities_0_Q1_USD":122000000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":23508000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":-19159000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":144000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":205636000.0,"EquitySecuritiesFvNi_0_Q1_USD":27400000.0,"IncomeTaxesPaidNet_1_Q1_USD":687000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":11253000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":12843000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":11755000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":12483840.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":3000000.0,"IncreaseDecreaseInReceivables_1_Q1_USD":25010000.0,"ContractWithCustomerLiability_0_Q1_USD":1900000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":61095000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent_1_Q1_USD":0.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":141985000.0,"MarketableSecuritiesRealizedGainLoss_1_Q1_USD":700000.0,"OperatingLeaseExpense_1_Q1_USD":5400000.0,"AssetsCurrent_0_Q1_USD":1122365000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":12150000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":20053000.0,"OperatingLeaseLiability_0_Q1_USD":85196000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease_1_Q1_USD":0.0,"FinanceLeaseLiability_0_Q1_USD":21747000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":451000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-10884000.0,"LettersOfCreditOutstandingAmount_0_Q1_USD":7500000.0,"FinanceLeasePrincipalPayments_1_Q1_USD":2224000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q1_USD":-302000.0,"InventoryWriteDown_1_Q1_USD":1400000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-1294000.0,"CommonStockValue_0_Q1_USD":70000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-1701000.0,"ProceedsFromSaleOfAvailableForSaleSecurities_1_Q1_USD":392093000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q1_USD":144000.0,"InventoryRawMaterials_0_Q1_USD":678000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":140469000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":134513000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":10242000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff_1_Q1_USD":0.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":45100000.0,"AvailableForSaleDebtSecuritiesGrossUnrealizedGain_1_Q1_USD":7900000.0,"GoodwillPeriodIncreaseDecrease_1_Q1_USD":0.0,"DepreciationDepletionAndAmortization_1_Q1_USD":13587000.0,"Liabilities_0_Q1_USD":1819365000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":77863000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":146632000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":11278000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-106428000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-128642000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":3000000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-28756000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-1963000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q1_USD":33000000.0,"RestrictedCash_0_Q1_USD":7500000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":100000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q1_USD":144000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":9531000.0,"ForeignCurrencyTransactionGainLossUnrealized_1_Q1_USD":-24691000.0,"NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_1_Q1_USD":8870000.0,"IndefinitelivedIntangibleAssetsAcquired_1_Q1_USD":576500000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-2154000.0,"CommonStockSharesIssued_0_Q1_shares":70405905.0,"Assets_0_Q1_USD":2111941000.0,"SaleOfStockNumberOfSharesIssuedInTransaction_1_Q1_shares":0.0,"AccountsPayableCurrent_0_Q1_USD":19114000.0,"LiabilitiesCurrent_0_Q1_USD":250949000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":13240000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q1_USD":450923000.0,"InventoryWorkInProcess_0_Q1_USD":8401000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-100157000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":25707000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-128191000.0,"Goodwill_0_Q1_USD":82341000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.078,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":750000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":22214000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":7489000.0,"AmortizationOfFinancingCosts_1_Q1_USD":452000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":154132000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":23601000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":11755000.0,"LongTermDebtNoncurrent_0_Q1_USD":430038000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":37123000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":240500000.0,"ReceivablesNetCurrent_0_Q1_USD":94124000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":136735000.0,"OperatingLeasePayments_1_Q1_USD":3406000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q1_USD":266050000.0,"DebtInstrumentInterestRateEffectivePercentage_0_Q1_pure":0.106,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":136074000.0,"AdditionalPaidInCapital_0_Q1_USD":2033972000.0,"ShortTermLeaseCost_1_Q1_USD":164000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0888,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":712574000.0,"AccruedIncomeTaxesCurrent_0_Q1_USD":3909000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":3000000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":7658000.0,"PaymentsToAcquireIntangibleAssets_1_Q1_USD":14192000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":2100000.0,"PaymentsToAcquireEquityMethodInvestments_1_Q1_USD":100000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":200000000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":2111941000.0,"OperatingLeaseCost_1_Q1_USD":4104000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":1887000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_1_Q1_USD":-100000.0,"IncreaseDecreaseInDepositOtherAssets_1_Q1_USD":-136000.0,"InventoryNet_0_Q1_USD":16234000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q1_USD":200000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":24859000.0,"OperatingIncomeLoss_1_Q1_USD":-98148000.0,"CommonStockSharesAuthorized_0_Q1_shares":125000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-15605000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":55273000.0,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_1_Q1_USD":7858000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingLeaseRightOfUseAsset_0_Q1_USD":82382000.0,"ShareBasedCompensation_1_Q1_USD":25707000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":117942000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":642077000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":25707000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":33826000.0,"CommonStockSharesOutstanding_0_Q1_shares":70405905.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-62180000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1702723000.0,"VariableLeaseCost_1_Q1_USD":1093000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":-1916000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-1359000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":641471000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":7333000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":5669000.0,"StockholdersEquity_0_Q1_USD":292576000.0,"OtherLiabilitiesCurrent_0_Q1_USD":1250000.0,"FinanceLeaseLiabilityCurrent_0_Q1_USD":1694000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":1392000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.83,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":13000.0,"OperatingExpenses_1_Q1_USD":216090000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q1_USD":0.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":4685000.0,"Ticker":"PTCT","CIK":"1070081","name":"PTC THERAPEUTICS, INC.","OfficialName":"PTC Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3106408363.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210504"}]